BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated with intravitreal therapies Growing preclinical and cli ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

AI chipmaker Nvidia ( NVDA) and pharmaceutical giant Eli Lilly ( LLY) on Monday announced that the two companies will jointly ...

After more than 30 years leading Charles River Laboratories International Inc., Jim Foster plans to retire from his role as ...

As of Thursday, January 08, Standard BioTools Inc.’s LAB share price has surged by 11.72%, which has investors questioning if ...

Formulatrix, a leader in laboratory automation solutions, and Spear Bio, an innovator in ultrasensitive protein biomarker ...

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034Precision Pathology Laboratory Services meets gold standard for excellence across all ...

Triethylamine is flagged for EPA regulation in 2026. The FDA is targeting chemicals with toxicity concerns. Environmental ...

The Forensic Science Laboratory Delhi has invited applications for Junior Scientific Assistant posts on a one-year contract ...

BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated with intravitreal therapies ...